Dietrich, Douglas
Reau, Nancy
Ahmed, Aijaz
Blissett, Rob
Igloi-Nagy, Adam
Yehoshua, Alon
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 2 May 2024
Accepted: 1 April 2025
First Online: 4 June 2025
Declarations
:
: Not applicable.
: DD has received consulting and speaking fees from Gilead Sciences. NR has received research funding and consulting fees from Gilead Sciences, AbbVie and Abbott. AA has received advisory and consulting fees from Gilead Sciences. AIN and RB are employees of Maple Health Group, LLC, which provides consulting services to Gilead Sciences.